Table 4 Type of complications and readmission between groups
From: Impact of clinical pathway on clinical outcomes in the management of COPD exacerbation
Characteristic | Non-Clinical Pathway (n = 38) | Clinical PathwayPValue (n = 14) |
|---|---|---|
Type of complications (n) | ||
Acute respiratory failure | 9 | 5 |
Hospital Acquired Pneumonia | 7 | 3 |
Acute Coronary Syndrome | 5 | 0 |
Congestive Cardiac Failure/ | 2 | 2 |
Fluid overload | ||
Acute Renal Failure | 3 | 2 |
Thromboplebitis/cellulitis | 3 | 1 |
Upper gastrointestinal bleeding | 1 | 0 |
Urinary tract infection | 2 | 0 |
Others | 6 | 2 |
Readmission (< 30 days) | ||
No | 76 (77.6) | 73 (76.8) *0.907 |
Yes | 22 (22.4) | 22 (23.2) |